These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3827260)

  • 1. [Intraperitoneal versus intravenous infusion of cis-platinum in advanced ovarian cancer--examination of pharmacokinetics].
    Shindo K; Oikawa N; Atsumi Y; Chida S; Tuburaya T; Yajima A
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):639-44. PubMed ID: 3827260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C; Huang R; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
    Miyagi Y; Fujiwara K; Kigawa J; Itamochi H; Nagao S; Aotani E; Terakawa N; Kohno I;
    Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of cis-diammine (glycolato) platinum (254-S), a new platinum antitumor agent, following an intravenous and intraperitoneal infusion bioactive platinum concentration profile].
    Hirabayashi K; Okada E; Oguma T; Shimamura K
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2221-7. PubMed ID: 2241186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
    Hayata S; Hitoshi T; Kiyokawa K; Esaki S; Mihashi S; Hirano M
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2356-61. PubMed ID: 6541891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.
    Howell SB; Pfeifle CE; Wung WE; Olshen RA
    Cancer Res; 1983 Mar; 43(3):1426-31. PubMed ID: 6681730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
    Horiuchi M; Inuyama Y; Kohno N; Mashino S; Fujii M
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):632-7. PubMed ID: 6892197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
    Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
    Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S.
    Ota K; Oguma T; Shimamura K
    Anticancer Res; 1994; 14(3B):1383-7. PubMed ID: 8067710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of gynecological cancer with cis-platinum].
    Mano T; Takeshima N; Nakamura Y; Tomimatsu T; Saito T; Miyake T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2895-9. PubMed ID: 3662545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfate.
    Canal P; de Forni M; Chatelut E; Chevreau C; Johnson NP; Houin G; Bugat R
    Acta Med Austriaca; 1989; 16(3-4):84-6. PubMed ID: 2609919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.
    Casper ES; Kelsen DP; Alcock NW; Lewis JL
    Cancer Treat Rep; 1983 Mar; 67(3):235-8. PubMed ID: 6682012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cis-diamminedichloroplatinum (II) given as low-dose and high-dose infusions.
    Kurihara N; Kubota T; Hoshiya Y; Otani Y; Ando N; Kumai K; Kitajima M
    J Surg Oncol; 1996 Jun; 62(2):135-8. PubMed ID: 8649040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.
    Panteix G; Beaujard A; Garbit F; Chaduiron-Faye C; Guillaumont M; Gilly F; Baltassat P; Bressolle F
    Anticancer Res; 2002; 22(2B):1329-36. PubMed ID: 12168946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
    Royer B; Delroeux D; Guardiola E; Combe M; Hoizey G; Montange D; Kantelip JP; Chauffert B; Heyd B; Pivot X
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
    Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; Raschko J; Chow W; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Carroll M; Vasilev S; Akman S; Coluzzi P; Wagman L; Longmate J; Paz B; Yen Y; Klevecz R
    Cancer Res; 1998 Jul; 58(13):2793-800. PubMed ID: 9661893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
    Kurihara N; Kumai K; Kubota T; Furukawa T; Yamamoto T; Shimada A; Shibata S; Saikawa Y; Ogawa S; Murayama Y
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1645-8. PubMed ID: 8373238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR; Cai GF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):224-6, 254. PubMed ID: 8404307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intraperitoneal administration of high doses of cisplatin in advanced ovarian carcinoma].
    Ptácková B; Kopecný J; Zatocil P; Anton M
    Cesk Gynekol; 1989 Mar; 54(2):106-9. PubMed ID: 2731237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.